News
Zacks.com on MSN20m
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
RXRX eyes Q2 earnings beat despite past misses, with a refocused pipeline and new data updates on key drug candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback